Purple yam-asparagus composition with anti-aging function as well as preparation method and application of purple yam-asparagus composition

Through the composition of purple yam and asparagus, the extraction of anthocyanins and polysaccharides using ultrasound-microwave collaborative extraction technology has solved the problems of complex ingredients and unknown mechanisms of existing anti-aging products, and achieved efficient and safe anti-aging effects. It is suitable for A variety of products have expanded the applicable population.

CN118903330APending Publication Date: 2024-11-08SUZHOU XINSHANYUAN BIOTECHNOLOGY CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411021572.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-29
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing anti-aging products have complex ingredients, unknown mechanisms, high costs and high potential risks, making it difficult to effectively solve the anti-aging needs brought about by the aging of the global population.

Method used

Develop a composition composed of purple yam and asparagus, extract anthocyanins and polysaccharides through ultrasonic-microwave synergistic extraction technology, and combine color protection agents, embedding agents and flavor regulators to prepare purple yam with anti-aging functions- Asparagus compositions, suitable for medicines, health products and foods.

Benefits of technology

Achieve anti-aging effects with non-toxic side effects and significantly improves the anti-aging function. Compared with the use of purple yam or asparagus extract alone, the composition significantly improves the effect. The applicable population is expanded. The product has bright color, sweet taste, mellow taste, and easy to use. Long-term consumption.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention belongs to the field of functional compositions, and particularly relates to a purple yam-asparagus composition with an anti-aging function as well as a preparation method and application of the purple yam-asparagus composition. The purple yam-asparagus composition with the anti-aging function is prepared from the following raw materials in parts by weight: 5-15 parts of purple yam and 3-9 parts of asparagus. According to the preparation method, the preparation is prepared by taking the medicinal and edible purple yam and asparagus as main raw materials through extraction and refining, and can be applied to the fields of medicines, health foods, foods and the like. The traditional Chinese medicine composition has the advantages of unique and simple formula, high extraction rate of effective components, remarkable function, no toxic or side effect, quick absorption, convenience in taking and the like, has an anti-aging function, and can be safely taken for a long time.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of functional compositions, and in particular relates to a purple yam-asparagus composition with anti-aging function, a preparation method and application thereof. Background Art

[0002] Medicine and food are of the same origin. This is the understanding and summary of the relationship between medicine and food in the production practice of Chinese people. It is applied in practice under the guidance of traditional Chinese medicine theory. The differences in the types and proportions of metabolites in medicine and food make the nature, taste and efficacy of the two different, which makes food focus on health preservation and medicine is mostly used for treatment. The application and development of medicine and food are of the same origin has become a major feature of modern health care. Based on the characteristics of medicine and food substances, products with diverse functions can be developed.

[0003] As the global population continues to age, the World Health Organization predicts that the global population over 60 will reach 2 billion in 2050, and the population over 65 will account for 15.6%. The global anti-aging market size has grown from US$139.5 billion in 2015 to US$216 billion in 2021, an increase of US$76.5 billion. In 2021, the global anti-aging market size will grow by 11.1% year-on-year. It is expected that the global anti-aging market size will maintain a high growth rate in the future, and the anti-aging market has huge development potential.

[0004] However, the current related products have complex ingredients, unclear mechanisms, high costs and potential risks. Based on this, the technical solution of the present invention is proposed. Summary of the invention

[0005] In order to solve the problems existing in the prior art, the present invention provides a purple yam-asparagus composition with anti-aging function, which is composed of the following raw materials in parts by weight: 5 to 15 parts of purple yam and 3 to 9 parts of asparagus.

[0006] For ease of understanding of the present invention, the raw materials of the present invention are described:

[0007] Purple yam (purple Dioscorea alata L) is a plant of the Dioscoreaceae family, Dioscorea zingiberensis, an annual or perennial herbaceous vine plant, mainly distributed in tropical and subtropical regions. It has been planted on a large scale in Guangxi Zhuang Autonomous Region and Zhejiang Province in my country. According to the Compendium of Materia Medica, purple yam has the effects of nourishing the lungs and kidneys, strengthening the spleen and stopping diarrhea. As a unique species in the Dioscorea genus, purple yam is also rich in anthocyanins and phenolic flavonoids that are not found in other Dioscorea plants.

[0008] Asparagus (Asparagus officinalis), also known as Asparagus officinalis, is a perennial herb of the Asparagus genus (Asparagus genus) of the Asparagaceae family. Young shoots can be eaten as vegetables. Asparagus, scientifically known as Asparagus officinalis, is a spring vegetable and a perennial flowering plant. Asparagus is cold in nature and can clear lung fire and lung dryness, which causes cough, sputum, hemoptysis and asthma. It has the effects of improving the body's immunity, helping to reduce high blood pressure, and clearing the throat. Asparagus is rich in selenium and flavonoids, has antioxidant effects, and has a good effect on preventing aging. The protective effect and antioxidant function of asparagus polysaccharides against radiation damage are considered to be the key material components of asparagus's anti-aging effect. At the same time, asparagus polysaccharides have an inhibitory effect on the expression of the P16 gene, which can also achieve the effect of alleviating the aging of mice.

[0009] Preferably, the purple yam-asparagus composition with anti-aging function is composed of the following raw materials in parts by weight: 10 parts of purple yam and 6 parts of asparagus.

[0010] Based on the same technical concept, the preparation method of the purple yam-asparagus composition with anti-aging function comprises the following steps:

[0011] (I) Preparation of purple yam extract:

[0012] (1) freeze-drying purple yam, crushing and sieving to obtain freeze-dried powder;

[0013] (2) mixing the lyophilized powder with sodium D-isoascorbate and citric acid, adding the mixture to ethanol, and subjecting the mixture to ultrasonic and microwave extraction. After the extraction, filtering is performed to obtain a filter residue and a supernatant; and concentrating the supernatant under reduced pressure to remove the ethanol, thereby obtaining a primary extract;

[0014] (3) adding the filter residue to water for ultrasonic and microwave extraction, and filtering to obtain a secondary extract after completion;

[0015] (4) mixing the primary extract and the secondary extract and concentrating under reduced pressure to obtain a purple yam extract;

[0016] (II) Preparation of Asparagus Extract:

[0017] (S1) juicing the asparagus to obtain asparagus juice;

[0018] (S2) adding a color preservative, an embedding agent and a flavor regulator to the asparagus juice to obtain an asparagus extract;

[0019] (III) Preparation of composition

[0020] The purple yam extract and the asparagus extract are mixed evenly.

[0021] Preferably, in step (1), the purple yam is freeze-dried and crushed through a 40-mesh sieve to obtain a freeze-dried powder.

[0022] Preferably, in step (2), the mass ratio of the lyophilized powder, sodium D-isoascorbate, citric acid, and ethanol is 1:0.00015:0.002:5-10;

[0023] And / or, in step (2), the power of the ultrasound is 300 W, the power of the microwave is 750 W, and the extraction time is 1 to 3 hours.

[0024] Preferably, in step (3), the power of the ultrasound is 300 W, the power of the microwave is 750 W, and the extraction time is 1 to 3 hours.

[0025] Preferably, in step (S2), the color protecting agent is L-ascorbic acid;

[0026] And / or, the embedding agent is β-cyclodextrin;

[0027] And / or, the flavor regulator is white sugar and ethyl maltol.

[0028] To facilitate understanding of the present invention, the relevant steps of the present invention are described:

[0029] The preparation method adopts ultrasound-microwave synergistic extraction technology to extract and purify anthocyanins in purple yam, and relevant parameters such as ultrasonic power, microwave power, and microwave time are determined through repeated attempts, which can also provide a reference for the extraction and pharmacological research of anthocyanins in purple yam and product development.

[0030] In addition, after squeezing the asparagus juice, a color preservative is added to the juice in time and stirred evenly to reduce the damage to the original color of the juice during the production process. This operation is the best color protection scheme determined after comparing the effects of different additives on the color of the finished product. At the same time, since asparagus peel contains bitter substances such as furostane saponins, the taste of asparagus juice is seriously affected. Considering that the bitter substances in asparagus have certain medicinal value, the present invention starts with technical processing from the perspective of embedding and seasoning, and studies the best way to eliminate the adverse effects of bitter components in asparagus juice.

[0031] Based on the same technical concept, the present invention further provides an application of a purple yam-asparagus composition with anti-aging function in the preparation of medicines, health products and foods.

[0032] Preferably, the dosage forms of the medicine, health care product and food are: granules, capsules, tablets, pills, oral liquids, plant beverages, solid beverages or tea bags. The final product obtained by the present invention has bright color, pink-purple color, retains the original purple color of purple yam, tastes sweet, slightly sour, has a mellow taste, and has the unique fragrance of yam and asparagus.

[0033] The beneficial effects of the present invention are:

[0034] 1. The present invention uses purple yam extract and asparagus plant juice as main components and has carried out scientific proportioning. By extracting and mixing purple yam and asparagus, the regulating effect of plant raw materials on human physiological functions is fully exerted. The final product has no toxic side effects and can be eaten for a long time.

[0035] 2. The present invention has been proved through experiments that the mixed extract of purple yam and asparagus has a synergistic effect in anti-aging and other functions. Compared with the single extract of purple yam and asparagus juice, the extract obtained by the mixed extraction of purple yam and asparagus of the present invention significantly improves the effect. Specifically, in the experiment, D-galactose was used to replicate the mouse aging model, and the number of autonomous activities of mice, brain, liver, heart, kidney, spleen index, SOD, GSH-Px, T-AOC, CAT activity and MDA content were measured to determine that the purple yam asparagus composition of the present invention has anti-aging function.

[0036] 3. The composition of the present invention has shown good effects in anti-aging experiments. At the same time, the mixed extraction method of the two also neutralizes the cold and hot properties, expands the applicable population and is conducive to long-term consumption.

[0037] 4. The composition product obtained by the present invention is determined to contain no less than 0.4 mg (0.9638 mg / g) of anthocyanins per 10 mL, which is much higher than the existing reported blueberry plant beverage (0.746 mg / g) and black wolfberry plant beverage products (0.786 mg / g). The polysaccharide content in the purple yam composition is also determined by sulfuric acid-phenol method, and the polysaccharide content in the purple yam composition is calculated according to the glucose standard curve. The polysaccharide content of each 10 mL of purple yam asparagus plant beverage is no less than 49.451 mg.

[0038] 5. The composition of the present invention has simple ingredients, unique formula, scientific dosage ratio, high extraction rate of effective components, significant functions, no toxic side effects, rapid absorption, convenient administration, and easy preparation. It can be made into a variety of medicines, health products or foods using a production-acceptable method. DETAILED DESCRIPTION

[0039] To make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described in detail below. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other implementation methods obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention.

[0040] Example 1

[0041] This embodiment provides a method for preparing a purple yam-asparagus composition with anti-aging function, the preparation method comprising:

[0042] (I) Preparation of purple yam extract:

[0043] (1) freeze-drying purple yam and crushing it through a 40-mesh sieve to obtain a freeze-dried powder;

[0044] (2) 100 g of freeze-dried powder, 0.015 g of sodium D-isoascorbate and 0.2 g of citric acid were added to 800 g of ethanol (30 wt.%), and ultrasonic extraction (300 W) and microwave extraction (750 W) were performed for 1 h. After completion, the residue and supernatant were obtained by filtration; and the supernatant was concentrated under reduced pressure to remove ethanol to obtain a primary extract;

[0045] (3) adding the filter residue to water for ultrasonic extraction (300W) and microwave extraction (750W) for 1 hour, and filtering to obtain a secondary extract after completion;

[0046] (4) mixing the primary extract and the secondary extract and concentrating under reduced pressure to obtain a purple yam extract;

[0047] (II) Preparation of Asparagus Extract:

[0048] (S1) adjusting the volume of asparagus to a material-water ratio of 1:20 (g / mL), and then squeezing the asparagus juice with a screw press to obtain asparagus juice;

[0049] (S2) adding L-ascorbic acid (0.5 wt.%), β-cyclodextrin (3 wt.%), white sugar (2 wt.%) and ethyl maltol (2 wt.%) to the asparagus juice to obtain an asparagus extract;

[0050] (III) Preparation of composition

[0051] The purple yam extract and the asparagus extract are evenly mixed in a mass ratio of 10:6.

[0052] Example 2

[0053] This embodiment provides a method for preparing a purple yam-asparagus composition with anti-aging function, the preparation method comprising:

[0054] (I) Preparation of purple yam extract:

[0055] (1) freeze-drying purple yam and crushing it through a 40-mesh sieve to obtain a freeze-dried powder;

[0056] (2) 100 g of freeze-dried powder, 0.015 g of sodium D-isoascorbate and 0.2 g of citric acid were added to 600 g of ethanol (30 wt.%), and ultrasonic extraction (300 W) and microwave extraction (750 W) were performed for 1.5 h. After completion, the residue and supernatant were obtained by filtration; and the supernatant was concentrated under reduced pressure to remove ethanol to obtain a primary extract;

[0057] (3) adding the filter residue to water for ultrasonic extraction (300W) and microwave extraction (750W) for 1.5 hours, and filtering to obtain a secondary extract after completion;

[0058] (4) mixing the primary extract and the secondary extract and concentrating under reduced pressure to obtain a purple yam extract;

[0059] (II) Preparation of Asparagus Extract:

[0060] (S1) adjusting the volume of asparagus to a material-water ratio of 1:20 (g / mL), and then squeezing the asparagus juice with a screw press to obtain asparagus juice;

[0061] (S2) adding L-ascorbic acid (0.5 wt.%), β-cyclodextrin (3 wt.%), white sugar (2.5 wt.%) and ethyl maltol (2.5 wt.%) to the asparagus juice to obtain an asparagus extract;

[0062] (III) Preparation of composition

[0063] The purple yam extract and the asparagus extract are evenly mixed in a mass ratio of 9:5.

[0064] Example 3

[0065] This embodiment provides a method for preparing a purple yam-asparagus composition with anti-aging function, the preparation method comprising:

[0066] (I) Preparation of Purple Yam Extract:

[0067] (1) freeze-drying purple yam and crushing it through a 40-mesh sieve to obtain a freeze-dried powder;

[0068] (2) 100 g of freeze-dried powder, 0.015 g of sodium D-isoascorbate and 0.2 g of citric acid were added to 1000 g of ethanol (30 wt.%), and ultrasonic extraction (300 W) and microwave extraction (750 W) were performed for 2 h. After completion, the residue and supernatant were obtained by filtration; and the supernatant was concentrated under reduced pressure to remove ethanol to obtain a primary extract;

[0069] (3) adding the filter residue to water for ultrasonic extraction (300W) and microwave extraction (750W) for 2 hours, and filtering to obtain a secondary extract after completion;

[0070] (4) mixing the primary extract and the secondary extract and concentrating under reduced pressure to obtain a purple yam extract;

[0071] (II) Preparation of Asparagus Extract:

[0072] (S1) adjusting the volume of asparagus to a material-water ratio of 1:20 (g / mL), and then squeezing the asparagus juice with a screw press to obtain asparagus juice;

[0073] (S2) adding L-ascorbic acid (0.5 wt.%), β-cyclodextrin (3 wt.%), white sugar (2.5 wt.%) and ethyl maltol (2.5 wt.%) to the asparagus juice to obtain an asparagus extract;

[0074] (III) Preparation of composition

[0075] The purple yam extract and the asparagus extract are evenly mixed in a mass ratio of 6:3.

[0076] Example 4

[0077] This embodiment provides a method for preparing a purple yam-asparagus composition with anti-aging function, the preparation method comprising:

[0078] (I) Preparation of purple yam extract:

[0079] (1) freeze-drying purple yam and crushing it through a 40-mesh sieve to obtain a freeze-dried powder;

[0080] (2) 100 g of freeze-dried powder, 0.015 g of sodium D-isoascorbate and 0.2 g of citric acid were added to 800 g of ethanol (30 wt.%), and ultrasonic extraction (300 W) and microwave extraction (750 W) were performed for 3 h. After completion, the residue and supernatant were obtained by filtration; and the supernatant was concentrated under reduced pressure to remove ethanol to obtain a primary extract;

[0081] (3) adding the filter residue to water for ultrasonic extraction (300W) and microwave extraction (750W) for 3 hours, and filtering to obtain a secondary extract after completion;

[0082] (4) mixing the primary extract and the secondary extract and concentrating under reduced pressure to obtain a purple yam extract;

[0083] (II) Preparation of Asparagus Extract:

[0084] (S1) adjusting the volume of asparagus to a material-water ratio of 1:20 (g / mL), and then squeezing the asparagus juice with a screw press to obtain asparagus juice;

[0085] (S2) adding L-ascorbic acid (0.5 wt.%), β-cyclodextrin (3 wt.%), white sugar (2.5 wt.%) and ethyl maltol (2.5 wt.%) to the asparagus juice to obtain an asparagus extract;

[0086] (III) Preparation of composition

[0087] The purple yam extract and the asparagus extract are evenly mixed in a mass ratio of 7:5.

[0088] Example 5

[0089] This embodiment provides a method for preparing a purple yam-asparagus composition with anti-aging function, the preparation method comprising:

[0090] (I) Preparation of purple yam extract:

[0091] (1) freeze-drying purple yam and crushing it through a 40-mesh sieve to obtain a freeze-dried powder;

[0092] (2) 100 g of freeze-dried powder, 0.015 g of sodium D-isoascorbate and 0.2 g of citric acid were added to 1000 g of ethanol (30 wt.%), and ultrasonic extraction (300 W) and microwave extraction (750 W) were performed for 2 h. After completion, the residue and supernatant were obtained by filtration; and the supernatant was concentrated under reduced pressure to remove ethanol to obtain a primary extract;

[0093] (3) adding the filter residue to water for ultrasonic extraction (300W) and microwave extraction (750W) for 2 hours, and filtering to obtain a secondary extract after completion;

[0094] (4) mixing the primary extract and the secondary extract and concentrating under reduced pressure to obtain a purple yam extract;

[0095] (II) Preparation of Asparagus Extract:

[0096] (S1) adjusting the volume of asparagus to a material-water ratio of 1:20 (g / mL), and then squeezing the asparagus juice with a screw press to obtain asparagus juice;

[0097] (S2) adding L-ascorbic acid (0.5 wt.%), β-cyclodextrin (3 wt.%), white sugar (2.5 wt.%) and ethyl maltol (2.5 wt.%) to the asparagus juice to obtain an asparagus extract;

[0098] (III) Preparation of composition

[0099] The purple yam extract and the asparagus extract are evenly mixed in a mass ratio of 12:8.

[0100] Experimental verification example

[0101] 1. Experimental methods

[0102] 1.1 Animal grouping and drug administration

[0103] Healthy KM mice were randomly divided into 6 groups: normal group, model control group, positive drug group (piracetam tablets, 600 mg / kg), low, medium and high dose (1.25 g / kg, 2.5 g / kg, 5 g / kg) groups of purple yam-asparagus composition (prepared in Example 1), with 10 mice in each group.

[0104] Except for the normal group, which was subcutaneously injected with saline at a dose of 0.1 mL / 10 g / d, the other groups were subcutaneously injected with D-galactose at the back of the neck at a dose of 150 mg / kg / d, with an injection volume of 0.1 mL / 10 g, for 30 consecutive days to create an aging model. At the same time as modeling, mice in the normal group and model group were gavaged with pure water at a dose of 0.2 mL / 10 g, the positive drug group was gavaged with 600 mg / kg of piracetam tablets, and the purple yam combination group was gavaged with 1.25 mg / kg, 2.5 mg / kg, and 5 mg / kg, respectively. The drug was administered continuously for 30 days.

[0105] 1.2 Determination of the number of spontaneous activities of mice

[0106] The number of spontaneous activities of mice in each group within 10 minutes was measured 60 minutes after the last administration.

[0107] 1.3 Determination of mouse organ index

[0108] On the second day after the last administration, the mice were killed by cervical dislocation, and the brain, liver, kidney, spleen, heart and other organs of the mice were quickly removed, washed with physiological saline to remove blood, dried with filter paper, weighed, and the organ index of the mice was calculated (Formula I).

[0109] Organ index (mg / g) = organ weight (mg) / body weight (g) ………… Formula I

[0110] 1.4 Determination of antioxidant enzyme activity and malondialdehyde content in mouse brain and liver tissues

[0111] The weighed brain and liver of the mice were taken, and the activities of various antioxidant enzymes, total antioxidant capacity and malondialdehyde content were determined according to the operating instructions of the kit.

[0112] 1.5 Statistical methods

[0113] SPSS18.0 statistical software was used for statistical analysis, and the differences among the groups were analyzed using t-test. p<0.05 indicated a significant difference, and p<0.01 indicated an extremely significant difference.

[0114] 2. Experimental results and analysis

[0115] 2.1 Effect of purple yam-asparagus combination on the number of spontaneous activities of mice

[0116] The number of spontaneous activities of mice within 10 minutes is shown in Table 1. As shown in Table 1, compared with the normal group, the number of spontaneous activities of mice in the model group within 10 minutes decreased significantly (p<0.05), and the number of spontaneous activities of mice increased significantly after administration, among which the low and high dose groups of purple yam combination had significant differences compared with the model group (p<0.05), and the medium dose group of purple yam and the positive drug group had extremely significant differences compared with the model group (p<0.01).

[0117] Table 1 Effects of each group on the number of spontaneous activities of mice (x±s, n=10)

[0118] Group Number of spontaneous activities within 10 minutes Normal group 552±57 Model Group <![CDATA[448±105 * ]]> Positive drug group <![CDATA[561±41 && ]]> Purple yam combination low dose group <![CDATA[524±45 & ]]> Medium dose group of purple yam composition <![CDATA[562±50 && ]]> Purple yam combination high dose group <![CDATA[540±41 & ]]>

[0119] Note: Compared with the blank group, * indicates significant difference (p<0.05); compared with the model group, & indicates significant difference (p<0.05), and && indicates extremely significant difference (p<0.01).

[0120] 2.2 Effects of purple yam-asparagus combination on organ indexes of mice

[0121] The results of the effect of the purple yam-asparagus combination on the organ indexes of mice are shown in Table 2. Compared with the normal group, the brain, liver, kidney, spleen and heart indexes of the mice in the aging model group were significantly reduced (p<0.05), among which the spleen index and heart index were significantly different from those in the normal group (p<0.01). Compared with the model group, the liver index and index of the positive drug group were significantly increased (p<0.05), and the brain index was significantly different (p<0.01). Compared with the model group, the brain index and heart index of the low-dose group of the purple yam-asparagus combination were significantly different (p<0.05); compared with the model group, the brain index, liver index and spleen index of the medium-dose group of the purple yam-asparagus were significantly different (p<0.05). Compared with the model group, the spleen index and heart index of the high-dose group of the purple yam-asparagus were significantly different (p<0.05), and the brain index was significantly different (p<0.01). There was no significant difference in brain index between the positive drug group and the purple yam-asparagus dose groups compared with the normal group (p>0.05), and the brain index and spleen index of the purple yam-asparagus group showed a certain dose-effect relationship with the concentration; while there was no significant difference in kidney index between the drug-treated groups and the model group (p>0.05).

[0122] Table 2 Effects of purple yam-asparagus combination on mouse organ indexes (x±s, n=10)

[0123]

[0124]

[0125] Table 2 (continued)

[0126] Group Spleen index Heart Index Normal group 8.45±2.17 6.18±0.58 Model Group <![CDATA[5.29±1.32 ** ]]> <![CDATA[5.47±0.48 ** ]]> Positive group 5.08±2.24 <![CDATA[6.08±0.69 & ]]> Low dose group 5.77±3.51 <![CDATA[6.09±0.62 & ]]> Medium dose group <![CDATA[7.51±2.95 & ]]> 5.47±0.99 High dose group <![CDATA[8.27±3.19 & ]]> <![CDATA[6.07±0.54 & ]]>

[0127] Note: Compared with the blank group, * indicates significant difference (p<0.05), ** indicates extremely significant difference (p<0.01); compared with the model group, & indicates significant difference (p<0.05), && indicates extremely significant difference (p<0.01)

[0128] 2.3 Effects of purple yam-asparagus combination on enzyme activity and malondialdehyde content in mouse brain tissue

[0129] The results of the effect of the purple yam-asparagus combination on the SOD, GSH-Px, T-AOC, CAT activities and MDA content in the brain tissue of mice are shown in Table 3. As shown in Table 3, compared with the blank group, the model group had a significant difference in GSH-Px activity (p<0.05), the SOD, CAT, and T-AOC activities had extremely significant differences (p<0.01), and the MDA content had a significant difference (p<0.05). Compared with the model group, the positive drug group had a significant difference in MDA content and GSH-Px activity (p<0.05), and the SOD, CAT, and T-AOC activities had extremely significant differences (p<0.01). Compared with the model group, the low-dose group of the purple yam-asparagus combination had a significant difference in SOD and T-AOC activities (p<0.05). Compared with the model group, the medium-dose group of purple yam-asparagus combination showed significant differences in SOD and GSH-Px activities (p<0.05), and extremely significant differences in CAT, T-AOC activities and MDA content (p<0.01). Compared with the model group, the high-dose group of purple yam-asparagus combination showed significant differences in GSH-Px activity (p<0.05), and extremely significant differences in SOD, CAT, T-AOC activities and MDA content (p<0.01).

[0130] Table 3 Effect of purple yam-asparagus combination on enzyme activity and malondialdehyde content in brain tissue (x±s, n=10)

[0131]

[0132] Table 3 (continued)

[0133] Group GSH-Px(U / mgprot) T-AOC (U / mgprot) Normal group 300.05±90.90 4.76±1.14 Model Group <![CDATA[225.32±42.92 * ]]> <![CDATA[2.91±0.99 ** ]]> Positive group <![CDATA[278.07±53.64 & ]]> <![CDATA[4.65±0.72 && ]]> Low dose group 240.70±48.07 <![CDATA[4.00±0.37 & ]]> Medium dose group <![CDATA[267.71±42.57 & ]]> <![CDATA[4.45±0.57 && ]]> High dose group <![CDATA[283.76±61.64 & ]]> <![CDATA[4.26±0.95 && ]]>

[0134] Note: Compared with the blank group, * indicates significant difference (p<0.05), ** indicates extremely significant difference (p<0.01); compared with the model group, & indicates significant difference (p<0.05), && indicates extremely significant difference (p<0.01).

[0135] 2.4 Effects of purple yam-asparagus combination on enzyme activity and malondialdehyde content in mouse liver tissue

[0136] The results of the effect of the purple yam-asparagus combination on the activities of SOD, GSH-Px, T-AOC, CAT and MDA content in the liver tissue of mice are shown in Table 4. Compared with the blank group, the activities of SOD, CAT, GSH-Px and T-AOC in the model group were significantly reduced (p<0.01), and the content of MDA was significantly increased (p<0.01). Compared with the model group, the activities of SOD, CAT, GSH-Px and T-AOC in the positive drug group were significantly increased, and the content of MDA was significantly decreased (p<0.05), among which the activity of T-AOC and the content of MDA had extremely significant differences (p<0.01). Compared with the model group, the low-dose group of the purple yam-asparagus combination had a significant increase in SOD activity (p<0.05), and T-AOC had an extremely significant difference (p<0.01). Compared with the model group, the activities of SOD, CAT, GSH-Px, and T-AOC in the medium-dose group of the purple yam-asparagus combination increased significantly (p<0.05), and the content of MDA decreased significantly (p<0.05), among which T-AOC had a very significant difference (p<0.01). Compared with the model group, the activities of SOD, GSH-Px, and T-AOC in the high-dose group of the purple yam-asparagus combination had a very significant difference (P<0.01), and the activity of CAT had a significant difference (p<0.05).

[0137] Table 4 Effect of purple yam-asparagus combination on enzyme activity and malondialdehyde content in liver tissue (x±s, n=10)

[0138]

[0139] Table 4 (continued)

[0140] Group GSH-Px (×500U / mgprot) T-AOC (U / mgprot) Normal group 592.16±38.97 6.38±1.28 Model Group <![CDATA[523.60±42.18 ** ]]> <![CDATA[2.34±0.70 ** ]]> Positive group <![CDATA[567.89±37.63 & ]]> <![CDATA[3.75±0.85 && ]]> Low dose group 531.97±44.83 <![CDATA[3.85±1.13 && ]]> Medium dose group <![CDATA[565.76±44.76 & ]]> <![CDATA[5.00±1.31 && ]]> High dose group <![CDATA[590.67±56.73 && ]]> <![CDATA[6.13±1.28 && ]]>

[0141] Note: Compared with the blank group, ** indicates a very significant difference (p<0.01); compared with the model group, & indicates a significant difference (p<0.05), and && indicates a very significant difference (p<0.01).

[0142] By measuring the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), total antioxidant capacity (T-AOC) and malondialdehyde (MDA) content in the body, the body's ability to scavenge free radicals can be determined, thereby reflecting the impact on aging.

[0143] The present invention uses D-galactose to replicate the mouse aging model, and investigates the anti-aging effect of the purple yam-asparagus composition on mice. The experimental results show that the number of autonomous activities of mice in the model group is significantly reduced, the brain, liver, kidney, spleen, and heart indexes are significantly reduced, the SOD, CAT, GSH-Px, and T-AOC activities in brain tissue and liver tissue are significantly reduced, and the MDA content is significantly increased. It shows that D-galactose successfully replicates the mouse aging model. Each dose group of piracetam tablets and purple yam-asparagus composition can significantly increase the number of autonomous activities of mice and the brain, liver, spleen, and heart indexes, increase the SOD, CAT, GSH-Px, and T-AOC activities in brain tissue and liver tissue, and reduce the MDA content, but there is no significant difference in the effect on the kidney index. The purple yam-asparagus composition has a certain dose-effect relationship on the brain index, spleen index, SOD, CAT, GSH-Px, T-AOC activity, and MDA content of mice.

[0144] The above is only a specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.

Claims

1. A purple yam-asparagus composition with anti-aging function, characterized in that: The invention is composed of the following raw materials in parts by weight: 5 to 15 parts of purple yam and 3 to 9 parts of asparagus.

2. The purple yam-asparagus composition with anti-aging function according to claim 1, characterized in that: The invention is composed of the following raw materials in parts by weight: 10 parts of purple yam and 6 parts of asparagus.

3. The method for preparing the purple yam-asparagus composition with anti-aging function according to claim 1 or 2, characterized in that: The preparation method comprises the following steps: (I) Preparation of purple yam extract: (1) freeze-drying purple yam, crushing and sieving to obtain freeze-dried powder; (2) mixing the lyophilized powder with sodium D-isoascorbate and citric acid, adding the mixture to ethanol, and subjecting the mixture to ultrasonic and microwave extraction. After the extraction, filtering is performed to obtain a filter residue and a supernatant; and concentrating the supernatant under reduced pressure to remove the ethanol, thereby obtaining a primary extract; (3) adding the filter residue to water for ultrasonic and microwave extraction, and filtering to obtain a secondary extract after completion; (4) mixing the primary extract and the secondary extract and concentrating under reduced pressure to obtain a purple yam extract; (II) Preparation of Asparagus Extract: (S1) juicing the asparagus to obtain asparagus juice; (S2) adding a color preservative, an embedding agent and a flavor regulator to the asparagus juice to obtain an asparagus extract; (III) Preparation of composition The purple yam extract and the asparagus extract are mixed evenly.

4. The method for preparing the purple yam-asparagus composition with anti-aging function according to claim 3, characterized in that: In step (1), purple yam is freeze-dried and crushed through a 40-mesh sieve to obtain freeze-dried powder.

5. The method for preparing the purple yam-asparagus composition with anti-aging function according to claim 3, characterized in that: In step (2), the mass ratio of the lyophilized powder, sodium D-isoascorbate, citric acid, and ethanol is 1:0.00015:0.002:5-10; And / or, in step (2), the power of the ultrasound is 300 W, the power of the microwave is 750 W, and the extraction time is 1 to 3 hours.

6. The method for preparing the purple yam-asparagus composition with anti-aging function according to claim 3, characterized in that: In step (3), the power of the ultrasound is 300 W, the power of the microwave is 750 W, and the extraction time is 1 to 3 hours.

7. The method for preparing the purple yam-asparagus composition with anti-aging function according to claim 3, characterized in that: In step (S2), the color protecting agent is L-ascorbic acid; And / or, the embedding agent is β-cyclodextrin; And / or, the flavor regulator is white sugar and ethyl maltol.

8. Use of the purple yam-asparagus composition with anti-aging function according to claim 1 or 2 in the preparation of medicines, health products and foods.

9. The use according to claim 9, characterized in that: The dosage forms of the medicine, health care product and food are: granules, capsules, tablets, pills, oral liquids, plant beverages, solid beverages or tea bags.

Citation Information

Patent Citations

  • Medicated diet having health-preservation effect

    CN106360461A